User login
Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer
JERSEY, Channel Islands, November 30, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Mr. Esteban Uriarte as the Company’s Chief Manufacturing Operations Officer (CMOO). Mr. Uriarte will assume the responsibilities of CMOO on…
Quotient Limited Announces Equity Awards
JERSEY, Channel Islands, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Ali Kiboro, who has been appointed as the Chief Financial Officer of the Company effective…
Quotient Limited Provides Business Update and Delays Releasing Second Quarter Fiscal 2022 Results
Quotient Limited to Report Second Quarter Fiscal Year 2022 Financial Results and Host Conference Call
Quotient Limited Announces receipt of Note Holders Consents to Indenture Amendments That Extend Maturity, Defer Principal Payments on 12% Senior Secured Notes
• Notes holders unanimously consent to amendments
• Company’s near-term cash obligations reduced by approximately $60 million
• Transaction extends liquidity runway through commercial launch and provides resources for further MosaiQ investment
• Company’s near-term cash obligations reduced by approximately $60 million
• Transaction extends liquidity runway through commercial launch and provides resources for further MosaiQ investment
Quotient Limited Announces Appointment of Chief Financial Officer
JERSEY, Channel Islands, October 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company’s Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1st, 2021, replacing Mr.…
Quotient Limited Announces Appointment of Chief Commercial Officer
JERSEY, Channel Islands, October 5, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced Mohammad El Khoury as the Company’s Chief Commercial Officer. In this role, Mr. El Khoury will oversee all commercial activities for the company as it…
Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
JERSEY, Channel Islands, October 4, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Dr. Christine Ginocchio as Chief Scientific & Medical Officer (CSMO).